Food & Beverage
Kolmar BNH gets approval for health functional food ingredient in US
This company develops its own balsam apple extract, used for blood sugar management
By Apr 20, 2023 (Gmt+09:00)
1
Min read
Most Read
LG Chem to sell water filter business to Glenwood PE for $692 million


Kyobo Life poised to buy Japan’s SBI Group-owned savings bank


KT&G eyes overseas M&A after rejecting activist fund's offer


StockX in merger talks with Naver’s online reseller Kream


Mirae Asset to be named Korea Post’s core real estate fund operator



Kolmar BNH Co. has received approval from the US Food and Drug Administration (FDA) for a domestically developed health functional food ingredient.
Kolmar BNH announced on Thursday that its individually recognized, balsam apple alcohol extract powder (Sugar Katcher S52™) has been approved by the FDA as a new dietary ingredient (NDI).
An NDI is a system in which the FDA authorizes the use of newly developed dietary ingredients. It must undergo evaluation processes such as ingredient, production, toxicity, and human application tests.
The newly listed ingredient was developed by Kolmar BNH's Food Science Lab, which studied and developed the unripe bitter melon alcohol extract powder for six years. Kolmar BNH has proven that unripe dried bitter melon, which has not yet formed seeds, activates substances that promote blood sugar metabolism and suppress body fat accumulation.
The company plans to develop products that improve the functionality and intake of unripe dried bitter melon extract powder based on the FDA's NDI approval and expand its presence in both domestic and international markets.
Write to Yoo-Rim Kim at youforest@hankyung.com
More to Read
-
Bio & PharmaS.Korea's Celltrion Healthcare launches Vegzelma in US
Apr 17, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaVaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer
Apr 14, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaS.Korea's FutureChem gets approval for phase 3 clinical trials in China
Mar 17, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaDaewoong wins approval for GERD treatment Fexuclu in Chile
Mar 14, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaGC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
Feb 21, 2023 (Gmt+09:00)
2 Min read
Comment 0
LOG IN